Background: US hospital discharge datasets typically report facility charges (ie, room and board), excluding professional fees (ie, attending physicians' charges).
licensed for independent practice, including many clinicians treating patients in hospitals. 10 A lack of professional fees is often identified as a limitation of cost analyses based on hospital discharge data. 11, 12 Some cost studies using such data have applied professional fee estimates generated from separate data sources. 13, 14 Limited information suggests facility-only costs might underestimate the full cost of hospital visits by 20%-25%. 14, 15 We aimed to estimate professional fee ratios (PFR) for inpatient admissions and treat-and-release ED (hereafter ED) visits for use in cost analyses based on hospital discharge data.
METHODS
We used medical claims data to estimate PFR for hospital discharge data. We posited that, consistent with limited previous estimates, professional fees might contribute an additional 20%-25% on top of facility fees to total hospital-based service costs. We identified admissions (including those originating in the ED) and ED visits among patients with commercial or Medicaid insurance reported in Truven Health MarketScan 2004-2012 databases. Market-Scan reports paid insurance claims and encounters from a selection of large employers, health plans, and government and public organizations, including approximately a dozen Medicaid state agencies. 16 MarketScan reports clinical diagnoses and associated payments to health care providers; charges submitted by providers are not reported. 17 The study period reflects availability of MarketScan variables that distinguish between facility and professional payments, 17 as well as a sufficient number of observations to estimate annual PFR stratified by selected clinical classifications [ie, Diagnostic Related Group (DRG)]. The primary outcome measures were associations between PFR and selected patient and service characteristics and estimated PFR per hospital admission or ED visit annually by insurance type (ie, commercial and Medicaid) and selected clinical classifications. Secondary outcome measures were annual overall adjusted mean PRF for admissions and ED visits by insurance type. Cost data are reported as 2012 USD using the Price Indexes for Personal Consumption Expenditures by Function from the US Bureau of Economic Analysis. 18 
PFR Definition
PFR was defined as the ratio of total payments to facility-only payments per admission or ED visit. On the basis of financial variables available in MarketScan, we calculated PFR per admission as total payment divided by the facilityonly payment to the hospital. 17 We calculated PFR per ED visit as the sum of facility and professional payments for ED services divided by the facility-only payment. The resulting PFR estimates were designed to be multiplied by facilityonly cost estimates from hospital discharge datasets to yield a total cost of care per visit. For example, if the estimated facility cost of a patient's admission reported in a hospital discharge dataset is $1000 and the corresponding estimated PFR for that patient's clinical diagnosis that year is 1.240, the total estimated direct medical cost of the admission could be calculated as $1240.
Clinical and Payment Classifications
MarketScan reports patients' clinical diagnoses based on administrative codes, including Major Diagnostic Category (MDC) (inpatient and ED), DRG (inpatient), and primary and other International Classification of Diseases, 9th revision, Clinical Modification (ICD-9-CM) diagnoses (inpatient and ED). We applied HCUP Clinical Classifications Software (HCUP-CCS) to report PFR by single-level HCUP-CCS (inpatient). 19 To ensure sufficient sample sizes for PFR estimates stratified by year and diagnosis, we assessed 3-digit, rather than the more specific 5-digit, ICD-9-CM classifications. We identified ED services among admitted patients using recommended criteria for the data source. 17 We combined patients' inpatient (and preceding ED, where applicable) and outpatient ED payment records and clinical information for services beginning on the same date and attributed the sum of payments and all associated clinical data to a single admission or ED visit. 17 Where >1 ICD-9-CM diagnosis was reported as the primary diagnosis for an admission (< 0.1% of analyzed admissions), we assigned the first-listed primary diagnosis as the primary diagnosis. We identified the primary diagnosis for ED visits based on the diagnosis to which facility payments were attributed. ED visits with >1 primary diagnosis associated with facility payments (< 0.5% of the sample) were excluded.
Sample Selection
We excluded admissions and ED visits with missing diagnostic information (ie, MDC, DRG, or ICD-9-CM primary diagnosis). We excluded admissions and ED visits with illogical diagnostic values (ie, E-code as primary ICD-9-CM diagnosis, or >1 DRG or MDC). We excluded admissions and ED visits with illogical payments (ie, negative or zero total payments or facility payments, or total payments that were less than reported facility payments).
We observed some admissions and ED visits with what appeared to be unreasonably low hospital facility payments, which created extreme PFR outliers; for example, facility payment <$1 for a multiday admission with professional payments of >$1000. The median inpatient facility payment per day was $2858 for commercially insured patients and $1570 for Medicaid patients over the study period. We excluded records with the lowest 1% of facility payments per hospitalized day (ie, <$298 for commercially insured patients and <$105 for Medicaid patients). The median ED treat-and-release facility payment was $532 for commercially insured patients and $139 for Medicaid patients. We excluded records with the lowest 1% of facility payments for ED visits (ie, <$32 for commercially insured patients and <$17 for Medicaid patients).
Patient and Service Characteristics
To estimate adjusted mean PFR we used multivariable regression models to control for factors associated with health care utilization and costs, and therefore hypothesized to influence professional fees: patient age (continuous variable), sex (dichotomous), race/ethnicity (categorical), health insurance plan type [ie, health maintenance organization (HMO), etc.; categorical], ED services preceding an admission (dichotomous), number of comorbidities (ie, hypertension, diabetes, etc.; continuous), surgery (dichotomous), treatment of medical complications (dichotomous), length of inpatient stay, discharge status (ie, to home, etc.; categorical), and the hospital's US state or regional location (ie, Connecticut or Northeast region, etc.; categorical). 20 Age for Medicaid patients was based on patients' year of birth. Race/ethnicity was available only for Medicaid patients. Adult (18 y old and above) comorbidities were defined by HCUP Comorbidity Software, Version 3.7, 3, 21 which identifies coexisting medical conditions that are not the primary reason for a hospital admission. This comorbidity classification relied on DRG information, which is not applicable to ED visits; therefore, only the inpatient PFR models controlled for comorbidities. For admissions among children and adolescents (below 18 y old), we also included as comorbidities selected childhood chronic conditions (developmental disabilities and congenital defects) defined by ICD-9-CM codes (see Table 1 notes). 22 In models based on MDC, CCS, and primary ICD-9-CM diagnosis, we included a variable for surgery based on the accompanying DRG (which is classified as surgical or medical) in the admission models or based on Current Procedural Terminology codes indicating surgery (10000-69999) in ED visit models. 23 Admission models controlled for treatment of medical complications, defined by ICD-9-CM codes (see Table 1 notes). 20 Hospital location was reported only for commercially insured admissions and ED visits; hospital state was reported for admissions but only region was reported for ED visits. Hospital state was included only in aggregate models of commercially insured admissions by year; in models of individual clinical classifications by year, smaller sample sizes dictated the use of hospital region, instead. Health insurance plan type, length of inpatient stay, and discharge status were analyzed as reported in the data source.
Analysis
Using admissions and ED visits as the units of analysis and PFR as the dependent variable, we first assessed associations between PFR and patient and service characteristics described previously using multivariable regression models. We then estimated adjusted mean PFR-as well as associated SE and 95% confidence intervals (CI)-calculated as the mean value of the model-predicted PFR for each admission or visit using Stata 13 (College Station, TX) margins program. 24 Among admissions, we estimated adjusted mean PFR first overall, stratified by year and insurance type and controlling for DRG, and then we estimated separate models for each clinical classification (ie, MDC, DRG, HCUP-CCS, and primary ICD-9-CM diagnosis) annually. 16, 25, 26 Among ED visits, we estimated adjusted mean PFR first overall, stratified by year and insurance type and controlling for MDC, and then we estimated separate models for each clinical classification (ie, MDC and primary ICD diagnosis) annually. Adjusted mean PFR estimates (hereafter simply PFR estimates) for clinical classifications with <100 observations are not reported. SAS 9.3 (Cary, NC) was used for sample selection and Stata 13 was used for modeling. PFR estimates as reported here were designed to be multiplied by facility-only hospital costs to estimate the total direct medical cost of admissions or ED visits based on financial information from hospital discharge data. Because of the computing power and time required for this selected presentation of results (ie, 1 model for each clinical diagnosis, by insurance type, each year-amounting to tens of thousands of models-and reporting estimated PFR per diagnosis and year as the mean value of model-predicted PFR for each admission or visit), we used ordinary least squares regression models with robust SE. Model results and PFR estimates for 2012 are reported in detail below. PFR estimates-as well practical use guidance-for admissions and ED visits 2004-2012 annually overall and by clinical diagnosis are reported below and in the accompanying Supplementary Digital Content (SDC) files (SDC Table 1 Figures 1 and 2 Among admissions for commercially insured patients, increased patient age was significantly associated with slightly lower PFR (ie, <0.1 percentage point lower per year of increased age) from 2004 to 2009 but was not significant from 2010 to 2012 (see Table 1 below for 2012 model results, see SDC Table 1 , Supplemental Digital Content 1, http://links. lww.com/MLR/B2 for model results for all study years). HMO health plans showed a significant but varied relationship with PFR compared with Comprehensive health plans (ie, plans with no incentive for patients to use particular providers 15 ). Other health plan types generally had significantly higher PFR (ie, 1-3 percentage points higher in 2012) compared with Comprehensive insurance. ED services preceding an inpatient admission and comorbidities were significantly associated with a higher PFR, as was surgery. Treatment of medical complications was associated with a significantly lower PFR, as was length of hospital stay. Admissions for patients who were transferred to another facility had higher PFR compared with patients discharged to home.
RESULTS

Sample selection is reported in
Among admissions for Medicaid patients, increased age and female sex were associated with slightly decreased PFR over the study period (see Table 1 below for 2012 model results, see SDC Table 1 , Supplemental Digital Content 1, http://links.lww.com/MLR/B2 for model results for all study years). Admissions among patients with black and other non-Hispanic race/ethnicity had significantly lower PFR compared with white patients, whereas admissions among Hispanic patients had a significant but varied relative relationship with PFR over the study period. ED visits preceding admissions, length of stay, discharge destination, and surgery demonstrated similar relationships to PFR as the commercially insurance models. Compared with Comprehensive health plans, HMO plans had significantly higher 19 and for children and adolescents (< 18 y old), also includes epilepsy/recurrent seizures (ICD-9-CM code 345), developmental delays (ICD-9-CM code 315), other nervous symptoms (ICD-9-CM code 781), congenital anomalies (ICD-9-CM-codes 740-759), conditions originating in the perinatal period (ICD-9-CM codes 760-779) and other chronic conditions (ICD-9-CM codes 299, 343, 317-319, 677, 369, 389). 20 8 Complications defined as the following secondary ICD-9-CM diagnosis codes on the admission record: 349.0, 349. PFR and patients with capitated plans had lower PFR over the study period. In the early part of the study period, admissions among patients with comorbidities had lower PFR, whereas in later years PFR was significantly higher. Treatment of medical complications did not demonstrate a consistent and significant association with PFR.
Among ED visits for both commercially insured and Medicaid patients, increased patient age was consistently and significantly associated with lower PFR (see Table 2 below for 2012 model results, see SDC Table 3 ). The overall estimated PFR for Medicaid admissions declined 3% (Table 3 ). Overall estimated PFR for ED visits also declined significantly for both commercially insured and Medicaid visits (13% and 3% declines, respectively) from 2004 to 2012 (Table 3) .
PFR estimates for the top 100 commercially insured inpatient admissions in the data source by DRG in 2012 based on number of admissions are reported in Table 4 . PFR estimates by all years and clinical classifications are reported in SDC Table 3 
DISCUSSION
In this study we quantified the amount by which facility-only financial data reported in hospital discharge datasets can underestimate the full cost of medical care patients receive during hospital admissions and ED visits by excluding professional fees. This study appears to be the first to comprehensively quantify professional fees in relation to facility fees for admissions and ED visits by year and clinical diagnosis. Financial information in MarketScan facilitated annual, diagnosis-specific PFR estimates, adjusted for multiple patient and service factors. Estimates by clinical classification reported in the SDC files were designed to be directly and easily applied to hospital discharge datasets for cost analysis.
This study had a number of limitations. Investigation into why PFR changed significantly over the study period or why differences exist between commercially insured and Medicaid PFR are beyond the scope of this study. Differences in the direction and significance of control variables' estimated coefficients in the annual regression models suggest variation in PFR based on issues we have not observed for this analysis. Such issues could conceivably span clinical trends, changes in patients' care-seeking behavior, policy changes that explicitly or inadvertently incentivized clinicians' diagnostic coding practices, or macroeconomic issues. MarketScan data are not nationally representative and the MarketScan Medicaid sample includes a limited number of states. US state and region are crude indicators of geographic differences in health care costs; we lacked consistent data to further control for geographic variation, such as urban/rural location. The study did not include admissions and ED visits covered by Medicare; the highest patient age among commercially insured admissions was 64 years. A future study could apply the methods described here to estimate PFR using Medicare claims data, which is available through separate MarketScan datasets for patients with employerbased supplemental insurance.
Some of the observed PFR per visit included in our analysis dataset were high (eg, as much as 137 for 2012 commercially insured admissions, indicating that professional fees were 137 times facility fees for the admission). That was despite excluding records with the lowest 1% of facility payments per inpatient day and facility payments per ED visit, based on the assumption that those payments represented transactions between hospitals and insurance providers based on random, anomalous, and proprietary factors that we could not track through the data source. With this exclusion criteria, the right-skewness of the PFR data shrunk substantially, providing a more even distribution at all levels. Observations remaining with relatively high PFR were plausible; for example, among admissions with PFR > 100 in 2012 all involved surgery with complications to multiple parts of the body (ie, specialist clinicians with high professional fees) with relatively limited hospital stays (ie, low facility costs).
MDC, DRG, and CCS clinical classifications are designed to be comprehensive descriptions of patients' health care needs during a particular admission or visit-and in the case of DRG, may be the basis of insurance companies' payments-whereas primary ICD-9-CM diagnoses provide a more limited clinical and financial explanation. For example, the designation of patients' primary diagnosis on hospital discharge records may be based on nonclinical decisions, including insurance reimbursement. 21 Researchers should apply PFR estimates by ICD-9-CM diagnosis with caution insurance. However, this study could not control for provider characteristics, such as physician specialty, and hospital facility characteristics, such as ownership, organization, and geographic location, which influence health care costs. 8, [27] [28] [29] [30] Hospitals' costs vary widely by service type; for example, Table 3 ). We selected a presentation of results we anticipated would be most relevant to cost analyses using hospital discharge data-that is, predicted PFR stratified by year and multiple clinical classifications. This aim limited our modeling options. The PFR distribution has a right tail, similar to distributions common among health care expenditure variables. Ordinary least squares models using transformed expenditure estimatesfor example, log or other transformations with variations such as the addition of a smearing retransformation factor-as depen-dent variables may produce more precise and robust estimates than direct analysis of untransformed expenditure variables. 32 However, retransformation to the original scale (required to fulfill our aim of reporting adjusted mean PFR for direct application to hospital discharge data) would have undermined the potential advantages of such an approach. One relic of this modeling approach is that the lower 95% CI of predicted PFR for a few clinical diagnoses was less than zero, and should not be regarded as credible. Generalized linear models are commonly used to model expenditure data, 33 although it was not feasible to use such models with our computing resources given the very large sample sizes (ie, 2.6 million admissions among commercially insured patients in 2012), the number of models estimated, and the presentation of results selected for direct application of PFR estimates to hospital discharge data. This study represents a first attempt at creating comprehensive data source for PFR estimates; future studies can improve upon the methods proposed here. This study estimated PFR per admission and ED visit based on payments that hospitals and physicians received for medical services, whereas hospital charges reported in hospital discharge data multiplied by CCR provide an estimate of hospitals' costs to provide services. Both approaches yield recognized estimates of medical costs, but this means that our PFR estimates are not precisely complementary to facility cost estimates from hospital discharge data. This issue might be mitigated by recent research suggesting CCR can be a reasonable proxy for price (or payments)-to-charge ratios, which are more directly analogous to our PFR estimates. 8 Despite what might be modest differences in the nature of financial data underlying our PFR estimates versus that underlying hospital discharge data, we propose that our approach offers a reasonable option for improving cost estimates from hospital discharge data by accounting for professional fees.
Excluding professional fees underestimates health care costs. Despite limitations, the PFR estimates generated in this study may offer an opportunity to address the systematic and substantial underestimation of health care service costs using facility-only costs reported in hospital discharge data. Adjustment for professional fees in some manner is recommended when hospital facility-only financial data are used to estimate health care costs.
